Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA. Ageing as a danger issue for neurodegenerative illness. Nat Rev Neurol. 2019;15:565–81.
Goedert M. Alpha-synuclein and neurodegenerative illnesses. Nat Rev Neurosci. 2001;2:492–501.
Kotzbauer PT, Trojanowsk JQ, Lee VM. Lewy physique pathology in Alzheimer’s illness. J Mol Neurosci. 2001;17:225–32.
Twohig D, Nielsen HM. α-synuclein within the pathophysiology of Alzheimer’s illness. Mol Neurodegener. 2019;14:23.
Alafuzoff I, Hartikainen P. Alpha-synucleinopathies. Handb Clin Neurol. 2017;145:339–53.
Savica R, Boeve BF, Mielke MM. When do α-synucleinopathies begin? An epidemiological timeline: a overview. JAMA Neurol. 2018;75:503–9.
Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger Okay, Attems J. Neuropathologically combined Alzheimer’s and Lewy physique illness: burden of pathological protein aggregates differs between scientific phenotypes. Acta Neuropathol. 2015;129:729–48.
Coughlin DG, Ittyerah R, Peterson C, Phillips JS, Miller S, Rascovsky Okay, Weintraub D, Siderowf AD, Duda JE, Hurtig HI, et al. Hippocampal subfield pathologic burden in Lewy physique illnesses vs. Alzheimer’s illness. Neuropathol Appl Neurobiol. 2020;46:707–21.
Ferman TJ, Aoki N, Criminal JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, et al. The limbic and neocortical contribution of alpha-synuclein, tau, and amyloid beta to illness period in dementia with Lewy our bodies. Alzheimers Dement. 2018;14:330–9.
Ferrucci L, Gonzalez-Freire M, Fabbri E, Simonsick E, Tanaka T, Moore Z, Salimi S, Sierra F, de Cabo R. Measuring organic getting older in people: a quest. Getting old Cell. 2020;19:e13080.
Royce GH, Brown-Borg HM, Deepa SS. The potential position of necroptosis in inflammaging and getting older. Geroscience. 2019;41:795–811.
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of getting older. Cell. 2013;153:1194–217.
Saez-Atienzar S, Masliah E. Mobile senescence and Alzheimer illness: the egg and the hen situation. Nat Rev Neurosci. 2020;21:433–44.
Hipp MS, Kasturi P, Hartl FU. The proteostasis community and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20:421–35.
Scott DA, Tabarean I, Tang Y, Cartier A, Masliah E, Roy S. A pathologic cascade resulting in synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci. 2010;30:8083–95.
Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol. 2010;6:702–6.
Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ. Inclusion formation and neuronal cell loss of life by neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 2009;106:13010–5.
Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A. Modeling Parkinson’s illness pathology by mixture of fibril seeds and α-synuclein overexpression within the rat mind. Proc Natl Acad Sci U S A. 2017;114:E8284-e8293.
Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949–53.
Lee HJ, Bae EJ, Lee SJ. Extracellular α–synuclein-a novel and essential consider Lewy physique illnesses. Nat Rev Neurol. 2014;10:92–8.
Van der Perren A, Gelders G, Fenyi A, Bousset L, Brito F, Peelaerts W, Van den Haute C, Gentleman S, Melki R, Baekelandt V. The structural variations between patient-derived alpha-synuclein strains dictate traits of Parkinson’s illness, a number of system atrophy and dementia with Lewy our bodies. Acta Neuropathol. 2020;139:977–1000.
Peralta Ramos JM, Iribarren P, Bousset L, Melki R, Baekelandt V, Van der Perren A. Peripheral irritation regulates CNS immune surveillance by the recruitment of inflammatory monocytes upon systemic α-synuclein administration. Entrance Immunol. 2019;10:80.
Surendranathan A, Rowe JB, O’Brien JT. Neuroinflammation in Lewy physique dementia. Parkinsonism Relat Disord. 2015;21:1398–406.
Allen Reish HE, Standaert DG. Position of α-synuclein in inducing innate and adaptive immunity in Parkinson illness. J Parkinsons Dis. 2015;5:1–19.
Gelders G, Baekelandt V, Van der Perren A. Linking neuroinflammation and neurodegeneration in Parkinson’s illness. J Immunol Res. 2018;2018:4784268.
Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.
Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, Hwang D, Masliah E, Lee SJ. Direct switch of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285:9262–72.
Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona Okay, Pieri L, Kiechle M, McLean PJ, Kassubek J, et al. Elevated immune activation by pathologic α-synuclein in Parkinson’s illness. Ann Neurol. 2019;86:593–606.
Hughes CD, Choi ML, Ryten M, Hopkins L, Drews A, Botía JA, Iljina M, Rodrigues M, Gagliano SA, Gandhi S, et al. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating position in Parkinson’s illness pathogenesis. Acta Neuropathol. 2019;137:103–20.
Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A, Fields JA, Masliah D, Iba M, Lee HJ, et al. Immunotherapy focusing on toll-like receptor 2 alleviates neurodegeneration in fashions of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Mol Neurodegener. 2018;13:43.
Caplan IF, Maguire-Zeiss KA. Toll-Like receptor 2 signaling and present approaches for therapeutic modulation in synucleinopathies. Entrance Pharmacol. 2018;9:417.
La Vitola P, Balducci C, Cerovic M, Santamaria G, Brandi E, Grandi F, Caldinelli L, Colombo L, Morgese MG, Trabace L, et al. Alpha-synuclein oligomers impair reminiscence by glial cell activation and through Toll-like receptor 2. Mind Behav Immun. 2018;69:591–602.
Dzamko N, Gysbers A, Perera G, Bahar A, Shankar A, Gao J, Fu Y, Halliday GM. Toll-like receptor 2 is elevated in neurons in Parkinson’s illness mind and should contribute to alpha-synuclein pathology. Acta Neuropathol. 2017;133:303–19.
Galiano-Landeira J, Torra A, Vila M, Bove J. CD8 T cell nigral infiltration precedes synucleinopathy in early levels of Parkinson’s illness. Mind. 2020;143:3717-33.
Lindestam Arlehamn CS, Garretti F, Sulzer D, Sette A. Roles for the adaptive immune system in Parkinson’s and Alzheimer’s illnesses. Curr Opin Immunol. 2019;59:115–20.
Iba M, Kim C, Sallin M, Kwon S, Verma A, Overk C, Rissman RA, Sen R, Sen JM, Masliah E. Neuroinflammation is related to infiltration of T cells in Lewy physique illness and alpha-synuclein transgenic fashions. J Neuroinflammation. 2020;17:214.
Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC. T cell infiltration and upregulation of MHCII in microglia results in accelerated neuronal loss in an alpha-synuclein rat mannequin of Parkinson’s illness. J Neuroinflammation. 2020;17:242.
Gate D, Tapp E, Leventhal O, Shahid M, Nonninger TJ, Yang AC, Strempfl Okay, Unger MS, Fehlmann T, Oh H, et al. CD4(+) T cells contribute to neurodegeneration in Lewy physique dementia. Science. 2021;374:868-74.
Zhang B, Kehm V, Gathagan R, Leight SN, Trojanowski JQ, Lee VM, Luk KC. Stereotaxic focusing on of alpha-synuclein pathology in mouse mind utilizing preformed fibrils. Strategies Mol Biol. 2019;1948:45–57.
Lecca D, Jung YJ, Scerba MT, Hwang I, Kim YK, Kim S, Modrow S, Tweedie D, Hsueh SC, Liu D, et al. Position of continual neuroinflammation in neuroplasticity and cognitive operate: a speculation. Alzheimers Dement. 2022. https://doi.org/10.1002/alz.12610.
Guilloux JP, Seney M, Edgar N, Sibille E. Built-in behavioral z-scoring will increase the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and intercourse. J Neurosci Strategies. 2011;197:21–31.
Earls RH, Menees KB, Chung J, Barber J, Gutekunst CA, Hazim MG, Lee JK. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice. J Neuroinflammation. 2019;16:250.
Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM. Artificial tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse mannequin of Alzheimer’s-like tauopathy. J Neurosci. 2013;33:1024–37.
Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi Okay, Spencer B, Worth DL, Patrick C, Desplats P, Masliah E. Hippocampal neuronal cells that accumulate alpha-synuclein fragments are extra susceptible to Abeta oligomer toxicity through mGluR5–implications for dementia with Lewy our bodies. Mol Neurodegener. 2014;9:18.
Wrasidlo W, Tsigelny IF, Worth DL, Dutta G, Rockenstein E, Schwarz TC, Ledolter Okay, Bonhaus D, Paulino A, Eleuteri S, et al. A de novo compound focusing on alpha-synuclein improves deficits in fashions of Parkinson’s illness. Mind. 2016;139:3217–36.
Paxinos G, Franklin KJ. The mouse mind in stereotaxic coordinates. third edn. Cambridge: Tutorial Press; 2007.
El-Agnaf O, Overk C, Rockenstein E, Mante M, Florio J, Adame A, Vaikath N, Majbour N, Lee SJ, Kim C, et al. Differential results of immunotherapy with antibodies focusing on alpha-synuclein oligomers and fibrils in a transgenic mannequin of synucleinopathy. Neurobiol Dis. 2017;104:85–96.
Younger Okay, Morrison H. Quantifying microglia morphology from photomicrographs of immunohistochemistry ready tissue utilizing imageJ. J Vis Exp. 2018;136:57648.
Schellinck HM, Cyr DP, Brown RE. What number of methods can mouse behavioral experiments go incorrect? Confounding variables in mouse fashions of neurodegenerative illnesses and methods to management them. In: Brockmann HJ, Roper TJ, Naguib M, Wynne-Edwards KE, editors. Advances within the examine of habits, vol. 41. Mitani JC: Simmons LW; 2010. p. 255–366.
Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, Effros RB, Chesselet MF. Regionally-specific microglial activation in younger mice over-expressing human wildtype alpha-synuclein. Exp Neurol. 2012;237:318–34.
Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh Okay, Federoff HJ. Synuclein prompts microglia in a mannequin of Parkinson’s illness. Neurobiol Getting old. 2008;29:1690–701.
Olah M, Patrick E, Villani AC, Xu J, White CC, Ryan KJ, Piehowski P, Kapasi A, Nejad P, Cimpean M, et al. A transcriptomic atlas of aged human microglia. Nat Commun. 2018;9:539.
Schaum N, Lehallier B, Hahn O, Palovics R, Hosseinzadeh S, Lee SE, Sit R, Lee DP, Losada PM, Zardeneta ME, et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature. 2020;583:596–602.
Ximerakis M, Lipnick SL, Innes BT, Simmons SK, Adiconis X, Dionne D, Mayweather BA, Nguyen L, Niziolek Z, Ozek C, et al. Single-cell transcriptomic profiling of the getting older mouse mind. Nat Neurosci. 2019;22:1696–708.
Chen J, Xu H, Aronow BJ, Jegga AG. Improved human illness candidate gene prioritization utilizing mouse phenotype. BMC Bioinformatics. 2007;8:392.
Motenko H, Neuhauser SB, O’Keefe M, Richardson JE. MouseMine: a brand new information warehouse for MGI. Mamm Genome. 2015;26:325–30.
Campos-Acuña J, Elgueta D, Pacheco R. T-cell-driven irritation as a mediator of the gut-brain axis concerned in Parkinson’s illness. Entrance Immunol. 2019;10:239.
Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in fashions of Parkinson’s illness. Nat Med. 2018;24:931–8.
Solar F, Salinas AG, Filser S, Blumenstock S, Medina-Luque J, Herms J, Sgobio C. Affect of alpha-synuclein spreading on the nigrostriatal dopaminergic pathway depends upon the onset of the pathology. Mind Pathol. 2022;32(2):e13036.
Harms AS, Delic V, Thome AD, Bryant N, Liu Z, Chandra S, Jurkuvenaite A, West AB. α-Synuclein fibrils recruit peripheral immune cells within the rat mind previous to neurodegeneration. Acta Neuropathol Commun. 2017;5:85.
Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V. Intestine-seeded alpha-synuclein fibrils promote intestine dysfunction and mind pathology particularly in aged mice. Nat Neurosci. 2020;23:327–36.
Stoyka LE, Arrant AE, Thrasher DR, Russell DL, Freire J, Mahoney CL, Narayanan A, Dib AG, Standaert DG, Volpicelli-Daley LA. Behavioral defects related to amygdala and cortical dysfunction in mice with seeded alpha-synuclein inclusions. Neurobiol Dis. 2020;134:104708.
Paumier KL, Luk KC, Manfredsson FP, Kanaan NM, Lipton JW, Collier TJ, Steece-Collier Okay, Kemp CJ, Celano S, Schulz E, et al. Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol Dis. 2015;82:185–99.
Sossi V, de la Fuente-Fernandez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth TJ, Aasly JO, Farrer MJ, Wszolek ZK, Stoessl JA. Dopamine turnover will increase in asymptomatic LRRK2 mutations carriers. Mov Disord. 2010;25:2717–23.
Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, et al. Elevated tonic extracellular dopamine focus and altered dopamine modulation of synaptic exercise precede dopamine loss within the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res. 2011;89:1091–102.
Unger EL, Eve DJ, Perez XA, Reichenbach DK, Xu Y, Lee MK, Andrews AM. Locomotor hyperactivity and alterations in dopamine neurotransmission are related to overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol Dis. 2006;21:431–43.
Rothman SM, Griffioen KJ, Vranis N, Ladenheim B, Cong WN, Cadet JL, Haran J, Martin B, Mattson MP. Neuronal expression of familial Parkinson’s illness A53T alpha-synuclein causes early motor impairment, lowered anxiousness and potential sleep disturbances in mice. J Parkinsons Dis. 2013;3:215–29.
Blesa J, Trigo-Damas I, Dileone M, Del Rey NL, Hernandez LF, Obeso JA. Compensatory mechanisms in Parkinson’s illness: circuits diversifications and position in illness modification. Exp Neurol. 2017;298:148–61.
Piancone F, Saresella M, La Rosa F, Marventano I, Meloni M, Navarro J, Clerici M. Inflammatory responses to monomeric and aggregated alpha-synuclein in peripheral blood of Parkinson illness sufferers. Entrance Neurosci. 2021;15:639646.
Nuber S, Rajsombath M, Minakaki G, Winkler J, Muller CP, Ericsson M, Caldarone B, Dettmer U, Selkoe DJ. Abrogating native alpha-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome carefully resembling Parkinson’s illness. Neuron. 2018;100(75–90):e75.
Shahmoradian SH, Lewis AJ, Genoud C, Hench J, Moors TE, Navarro PP, Castano-Diez D, Schweighauser G, Graff-Meyer A, Goldie KN, et al. Lewy pathology in Parkinson’s illness consists of crowded organelles and lipid membranes. Nat Neurosci. 2019;22:1099–109.
Trudler D, Levy-Barazany H, Nash Y, Samuel L, Sharon R, Frenkel D. Alpha synuclein deficiency will increase CD4(+) T-cells pro-inflammatory profile in a Nurr1-dependent method. J Neurochem. 2020;152:61–71.
Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ, Harding CV, Maitta RW. A crucial position for alpha-synuclein in improvement and performance of T lymphocytes. Immunobiology. 2016;221:333–40.
Xiao W, Shameli A, Harding CV, Meyerson HJ, Maitta RW. Late levels of hematopoiesis and B cell lymphopoiesis are regulated by alpha-synuclein, a key participant in Parkinson’s illness. Immunobiology. 2014;219:836–44.
Pangrazzi L, Weinberger B. T cells, getting older and senescence. Exp Gerontol. 2020;134:110887.
Angelova DM, Brown DR. Microglia and the getting older mind: are senescent microglia the important thing to neurodegeneration? J Neurochem. 2019;151:676–88.
Chen Z, Chen S, Liu J. The position of T cells within the pathogenesis of Parkinson’s illness. Prog Neurobiol. 2018;169:1–23.
Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, et al. α-Synuclein-specific T cell reactivity is related to preclinical and early Parkinson’s illness. Nat Commun. 1875;2020:11.
Williams GP, Marmion DJ, Schonhoff AM, Jurkuvenaite A, Received WJ, Standaert DG, Kordower JH, Harms AS. T cell infiltration in each human a number of system atrophy and a novel mouse mannequin of the illness. Acta Neuropathol. 2020;139:855–74.
Chandra G, Roy A, Rangasamy SB, Pahan Okay. Induction of adaptive immunity results in nigrostriatal illness development in MPTP Mouse Mannequin of Parkinson’s illness. J Immunol. 2017;198:4312–26.
Search engine optimisation J, Park J, Kim Okay, Received J, Yeo HG, Jin YB, Koo BS, Lim KS, Jeong KJ, Kang P, et al. Continual Infiltration of T Lymphocytes into the mind in a non-human primate mannequin of Parkinson’s illness. Neuroscience. 2020;431:73–85.
Sterling JK, Kam TI, Guttha S, Park H, Baumann B, Mehrabani-Tabari AA, Schultz H, Anderson B, Alnemri A, Chou SC, et al. Interleukin-6 triggers poisonous neuronal iron sequestration in response to pathological alpha-synuclein. Cell Rep. 2022;38:110358.
Dikmen HO, Hemmerich M, Lewen A, Hollnagel JO, Chausse B, Kann O. GM-CSF induces noninflammatory proliferation of microglia and disturbs electrical neuronal community rhythms in situ. J Neuroinflammation. 2020;17:235.
Gruntenko EV, Nikolin VP, Matienko NA, Kaledin VI, Vakhrusheva TA. Liposomes because the carriers of antitumor chemical preparations in neoplastic liver lesions. Dokl Akad Nauk SSSR. 1982;265:225–8.
Earls RH, Lee JK. The position of pure killer cells in Parkinson’s illness. Exp Mol Med. 2020;52:1517–25.
Walker DG. Defining activation states of microglia in human mind tissue: an unresolved situation for Alzheimer’s illness. Neuroimmunol Nueoinflamm. 2020;7:194–214.
Hercus TR, Broughton SE, Ekert PG, Ramshaw HS, Perugini M, Grimbaldeston M, Woodcock JM, Thomas D, Pitson S, Hughes T, et al. The GM-CSF receptor household: mechanism of activation and implications for illness. Progress Components. 2012;30:63–75.
Chitu V, Gokhan S, Gulinello M, Department CA, Patil M, Basu R, Stoddart C, Mehler MF, Stanley ER. Phenotypic characterization of a Csf1r haploinsufficient mouse mannequin of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP). Neurobiol Dis. 2015;74:219–28.
Chitu V, Biundo F, Shlager GGL, Park ES, Wang P, Gulinello ME, Gokhan S, Ketchum HC, Saha Okay, DeTure MA, et al. Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling. Cell Rep. 2020;30(3004–3019):e3005.
Walker DG, Tang TM, Lue LF. Research on colony stimulating issue receptor-1 and ligands colony stimulating factor-1 and interleukin-34 in Alzheimer’s illness brains and human microglia. Entrance Getting old Neurosci. 2017;9:244.
Beraud D, Maguire-Zeiss KA. Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson’s illness. Parkinsonism Relat Disord. 2012;18(Suppl 1):S17-20.
